The American College of Cardiology (ACC) has launched the EP Device Implant Registry, which will include data on ICD and CRT-D procedures previously captured in the NCDR ICD Registry as well as provide the flexibility to capture novel pacemaker procedures. The registry is aligned with the ACC’s Electrophysiology Accreditation programme, fully supporting the program’s data requirements.
“The expanded scope of the EP Device Implant Registry will allow hospitals to track new and existing procedures, giving them the ability to optimise patient care and outcomes,” said NCDR Management Board Chair Frederick A Masoudi. “The registry is well-positioned to support continuous quality assessment and improvement in the growing EP procedure service line.”
In addition, the EP Device Implant Registry now allows participants to capture data on shared decision-making, a compliance requirement for the CMS National Coverage Determination for ICD/CRT-D primary prevention device implants.
Since its inception in 2005, the ICD Registry has been the national standard for understanding patient selection, care and outcomes in patients receiving ICD therapy. The new EP Device Implant Registry will continue to empower the patient care team in their decision making by providing nationally benchmarked data on patient care and outcomes for broader range of devices. Over 800 US based hospitals currently participate in the EP Device Implant Registry.
